Physician

Jeffrey W Collins, D.O.

According to 2025 Medicare claims, Jeffrey Collins, D.O. (NPI: 1174942403) practices dermatology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is INTEGRATED DERMATOLOGY OF SANTA ROSA, PC (NPI: 1508441247; TIN: 86-1622079) and primary practice location at 95409-9998.

Collins' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,399 traditional Medicare patients, billed 6,870 HCPCS/CPT codes, and received $592,411 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 871 prescription claims across 456 beneficiaries totaling $245,185 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 17 records totaling $326. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $119,502 to $592,411. Similarly, Part D prescription costs have risen steadily, from $1,356 to $245,185. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$296K$592K2019 Medicare payment: $119,502 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $193,814 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $203,609 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $447,725 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $514,026 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $592,411 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20194421,790$119,502
20205842,822$193,814
20216402,437$203,609
20221,0745,240$447,725
20231,2466,473$514,026
20241,3996,870$592,411

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$171K$342K2015 Drug cost: $1,356 (USD; Tot_Drug_Cst)2017 Drug cost: $3,430 (USD; Tot_Drug_Cst)2018 Drug cost: $25,857 (USD; Tot_Drug_Cst)2019 Drug cost: $69,773 (USD; Tot_Drug_Cst)2020 Drug cost: $341,866 (USD; Tot_Drug_Cst)2021 Drug cost: $216,190 (USD; Tot_Drug_Cst)2022 Drug cost: $62,773 (USD; Tot_Drug_Cst)2023 Drug cost: $231,860 (USD; Tot_Drug_Cst)2024 Drug cost: $245,185 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151427$1,356
2016N/RN/RN/R
20172651$3,430
20183043$25,857
2019146260$69,773
2020302732$341,866
2021315656$216,190
2022361636$62,773
2023439820$231,860
2024456871$245,185

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths480588$92
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more701918$72
11102Biopsy of related skin growth, first growth325377$66
17000Destruction of precancer skin growth, 1 growth586724$38
17003Destruction of precancer skin growth, 2-14 growths3991,808$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab20546$76,363
Taltz AutoinjectorIxekizumab11308$74,853
FluorouracilFluorouracil1073,120$6,365
Triamcinolone AcetonideTriamcinolone Acetonide1353,656$1,491
KetoconazoleKetoconazole631,750$1,012

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$326ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffrey W. Collins, D.O.?

Tedicare shows public-source Medicare data for Jeffrey W. Collins, D.O. (NPI 1174942403), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey W. Collins, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey W. Collins, D.O.?

Jeffrey W. Collins, D.O. is linked to INTEGRATED DERMATOLOGY OF SANTA ROSA, PC (billing NPI 1508441247) in the available physician profile data.

Does Jeffrey W. Collins, D.O. have Open Payments data?

Jeffrey W. Collins, D.O. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.